The ligand for CD40 (CD40L) is a membrane protein on activated T cells that induces B cell proliferation and differentiation. Several mutations of the CD40L gene were reported responsible for defective class switching of B cells in an X-linked immunodeficiency with hyper IgM (X-HIM).
Introduction
Immunodeficiency with hyper IgM (HIM)' is a rare disorder characterized by recurrent bacterial infections associated with very low or absent IgG, IgA, and IgE and normal to increased IgM serum levels (1) . Evidence for clinical heterogeneity has been provided by the demonstration that the HIM syndrome can be either occur as a primary or as an acquired disorder (2, 3) . Primary HIM is a very rare disease, which accounts for as little as 0.3-2.0% of all primary immunodeficiencies (4).
Several reported pedigrees are consistent with an X-linked inheritance. However, occurrence in females suggest that primary HIM syndrome can also be inherited as an autosomaldominant transmission (1, 3) . Immune abnormalities in HIM syndrome are in most cases restricted to B cells with secretion of IgM only (5, 6) . However, some patients have been reported with concomitant cellular immune defects resulting in a combined immune deficiency (7) .
The CD40 cell surface antigen on B cells acts as a receptor capable of transmitting a signal (8, 9) . The ligand for CD40 is a membrane glycoprotein on activated T cells and the recent isolation and characterization of cDNA clones encoding gp39 have made possible the detailed study of this receptor-ligand pair and it's role in B cell activation (10) (11) (12) . A series of experiments have revealed that the signals delivered to B cells via CD40 can synergize with other costimulatory signals to drive B cell proliferation and differentiation (13) (14) (15) (16) . In X-HIM patients, a series of recent papers reported that CD4OL expression is incomplete on the surface of activated T cells and the defect is due to several distinct mutations of the gene coding for CD40L (17) (18) (19) (20) . The resultant failure of CD40 and ligand interaction is suggested responsible for the Ig isotype switching defects. It is also reported that in vitro signaling through CD40 rescues not only IgE but also IgG and IgA production (19, 21) In the this study, we confirmed independent mutations of the CD40L gene among different X-HIM families. However, signaling through CD40 rescues only IgE production by pa Amino acid sequence analysis of genes coding for CD40L IL-2-dependent T cell lines from patients and EB virus transformed B cell lines were established by methods described elsewhere (23) . Total RNA was extracted and reverse transcription of CD40L mRNA to cDNA was done according to standard methods using the primer for CD40L (19 supplemented with 10% FCS (Sterile Systems, Logan, UT), 2 mM glutamine. IL-10 (100 ng/ml; Genzyme Corp., Boston, MA) and IL-4 (Genzyme, 100 U/ml) were added to the culture at the first day. Supernatants were harvested on day 14 and IgE concentration was determined by previously described enzyme linked immuno-sorbent assay (ELISA, 26) with some modification. In brief, microplates (Nunc-Immunoplate, Maxisorp, Denmark) were coated with 100 pd of anti-human IgE antibody (6-90, 1 Isg/ml) over night at 4°C. After blocking with 0.1% of BSA, a total volume (100 pl) of diluted supernatant was assayed. After 2 h incubation at room temperature, alkaline phosphatase labeled antihuman IgE mAb (8-73) was added and incubated for 2 h at room temperature. After washing the wells four times, 100 tsl ofp -nitrophenyl phosphate substrate (Sigma Chemical Co., St. Louis, MO) solution was added to each well and absorbance at 405 nm was examined with an ELISA reader (ImmunoReader Nr-2000, InterMed). Purified IgE from IgE myeloma cell line U266 was used as the standard. IgM, IgG, and IgA secretion was also examined by isotype specific ELISA (Tago Inc., Burlingame, CA) as reported previously (24) .
Preparation of CD4+ T cell clones and cell culture. T cells separated by E rosette formation were stimulated with PHA (10 ,ug/ml; Difco Laboratories Inc., Detroit, MI) and IL-2 (1 U/ml; Takeda, Osaka, Japan) every 4 d. After limiting dilution, CD4+ clones were selected and expanded in Opti-MEM (GIBCO-BRL, Gland Island, NY) liquid medium supplemented with 10% FCS and further stimulated weekly with feeder cells (27) . CD4+ T cell clones from a healthy brother express normal CD40L but those from case I express a mutation leading to a truncated CD4OL ( 19 (Fig. 1) , turning the respective codon into a stop codon. This point mutation was reported to express a truncated CD40L on T cells (19) . In a family study, the father and a healthy brother did not have the mutation, but the mother had an affected and an intact CD40 gene, which confirmed the X-linked trait. The cDNAs obtained from case 3 and 4 had new mutations. Case 3 had a point mutation at nucleotide 766, resulting in an exchange of valine for glutamic acid, and case 4 had a deletion at 692-693. In a female HIM and two male type I CVI (22) patients, no mutation was found. These results confirm a series of papers (17) (18) (19) (20) that the patients diagnosed X-HIM have several mutations in CD40L gene. Induction of immunoglobulin secretion in MNC from HIM patients. Recently, anti-CD40 plus IL-lO was reported to induce class switching from IgM to other isotypes of Ig in X-HIM patients (19, 21) . MNC from X-HIM patients and a healthy brother of case 1 and 2 were stimulated with anti-CD40 (5C3) The stimulation of SAC plus anti-CD40 and IL-10 was reported to induce maximum Ig secretion in X-HIM (19) . Patients' MNC were stimulated by these B-cell mitogens for 14 d. In a healthy control, induction of IgG and A secretion was observed significantly (Fig. 2) . In all four X-HIM patients tested, however, there was no induction of IgG and IgA secretion. Again induction of IgM secretion was as much as healthy controls. These results suggest that anti-CD40 antibody does not rescue IgG or IgA production in X-HIM B cells. (Table II) . CD4+ T cell clone from the healthy brother induced proliferation on both B cells significantly. However, CD4+ T cell clone from case 1 did not induce B cell proliferation at all. Anti-CD40, as a control, induced proliferation moderately on both B cells. These results suggest that both CD40L and this anti-CD40 can activate X-HIM B cells. Induction of Ig secretion in X-HIM B cells by CD40L. Further experiments were carried out to examine whether CD40L on CD4+ T cell clones can correct the defective IgG and IgA production in X-HIM (Table HI) . Irradiated CD4+ T cell clones and IL-10 were cultured with X-HIM B cells. The CD4+ T cell clone from-the healthy brother induced not only IgM but also IgG and IgA production by his B cells. However, the same T cell clone failed to induce IgG and IgA production by the HIM patient's B cells. Even in the healthy brother's B cells, CD4+ T cells from HIM patient did not induce Ig secretion at all. These results suggest that CD40L does not correct defective IgG or IgA production in X-HIM B cells.
Induction of IgE production in X-HIM patients. In further experiments, IgE production was examined. MNC from X-HIM patients were stimulated by anti-CD40, IL-4, and IL-10 for 14 d and IgE secretion was examined by ELISA. Anti-CD40 plus IL-4 induced small amount of IgE production (Fig. 3) . When IL-10 was added to the culture, anti-CD40 plus IL-4 induced significant IgE production in every patient tested. The amount of IgE production in X-HIM patient is as much as that of the healthy control. In contrast, anti-CD40 alone did not induce IgE secretion at all. These result show that production of IgE can be induced by cross-linking of CD40.
Discussion
In all X-HIM families examined, several mutations including new mutations of CD40L were confirmed. Recent studies on X-HIM show that CD40L expression is incomplete and the defect is due to several mutations of genes coding for CD40L (17) (18) (19) (20) 29 (22) .
The data of B cell function presented herein, however, are quite different from those of previous papers that describe signaling through CD40 rescues not only IgE but also IgG and IgA (18, 19, 21) . In the present study, B cell defects of class switching for IgG and IgA were not rescued by any in vitro signaling through CD40 examined.
The reasons for the difference between former and present papers are not clear at present but several possibilities could be postulated. It is conceivable that the difference might be due to a different pattern of mutation in CD40L gene. However, in two patients (case 1 and 2), the same point mutation is found as in a patient T.G. (19) . Even (1) .
We hope that these observations will provide the basis for further and more sophisticated delineation of immunoregulatory abnormalities in this disease.
